Vice President, Clinical Operations
Dr Karen O’Hanlon is an experienced programme manager, with more than 17 years’ experience in preclinical, clinical and analytical drug development. Karen has a strong track record of leading experienced project teams across all functions and has multiple therapy area expertise, including oncology, gene therapy and virology.
Previously, Karen owned Blue Duck Consultancy Ltd which she set up in 2013 to provide program and project management for preclinical and clinical phase I-IV studies through a global network of CRA consultants. Karen’s role involved clinical study monitoring and set up, site set up and liaison, stand-alone ethics submissions, feasibility studies, medical writing and training.
Boyds has brought Karen’s clinical monitoring services under its regulatory and medical monitoring support services umbrella to strengthen its ability to identify therapies that will benefit patients.
Karen’s career has spanned various project management roles including Project Director at hVIVO, Clinical and Laboratory Project Manager and Feasibility and Program Manager at SRA Global Clinical Development and Preclinical and Clinical Project Manager at MediGene GmbH.
Prior to this, Karen was a Consultant Project Manager (veterinary medicine) at Triveritas and a Preclinical Business Co-Ordinator (Program Manager) and Project Leader (in vivo metabolism) at Charles River Laboratories.
Karen completed her post-doctoral research at the Wellcome Trust Centre for Cell Matrix Research in Manchester.
She has a BSc (Hons) in Medical Biochemistry from the University of Glasgow and a PhD in Biochemistry from the University of Manchester.
Crewe Business Park
CW1 6GL, UK
T +44 (0)1270 270010
F +44 (0)1270 253832
M +44 (0)7881 780249
- +44 (0)1270 270010